Showing results (361-370 of 552) with videos related to
Sort By:
Pageof 56
Journal of the American Academy of Dermatology|February 21, 2021
Metformin is associated with decreased risk of basal cell carcinoma: A whole-population case-control study from IcelandJonas A Adalsteinsson, Sonal Muzumdar, Reid Waldman, et al.Journal of the American Academy of Dermatology|February 18, 2026
The 487-gene expression profile test guides systemic therapy selection to improve outcomes for patients with atopic dermatitis: Results from a prospective trialJonathan I Silverberg, Lawrence F Eichenfield, April W Armstrong, et al.The Journal of Dermatological Treatment|September 25, 2024
Disease burden and patient characteristics associated with systemic therapy utilization among adults with atopic dermatitis: data from CorEvitas Atopic Dermatitis RegistryJonathan I Silverberg, Linda Stein Gold, Seemal Desai, et al.Eclinicalmedicine|July 3, 2023
Efficacy and safety of topically applied therapeutic ammonia oxidising bacteria in adults with mild-to-moderate atopic dermatitis and moderate-to-severe pruritus: a randomised, double-blind, placebo-controlled, dose-ranging, phase 2b trialJonathan I Silverberg, Peter A Lio, Eric L Simpson, et al.Dermatology and Therapy|April 18, 2022
Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysisJonathan I Silverberg, H Chih-Ho Hong, Jacob P Thyssen, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 6, 2022
Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitisAndrew Blauvelt, Leon Kircik, Kim A Papp, et al.The Journal of Dermatological Treatment|December 11, 2024
Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registryJonathan I Silverberg, Brian M Calimlim, Ayman Grada, et al.Dermatology (Basel, Switzerland)|December 11, 2023
Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic DermatitisJacob P Thyssen, Anthony Bewley, Sonja Ständer, et al.Acta Dermato-Venereologica|October 7, 2021
Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic DermatitisJonathan I Silverberg, Eric L Simpson, Mark Boguniewicz, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 17, 2022
Pharmacology of orismilast, a potent and selective PDE4 inhibitorJonathan I Silverberg, Lars E French, Richard B Warren, et al.Pageof 56